<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN""http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html><head><title>Patent US5741705 - Method for in vitro cell growth of eucaryotic cells using low molecular ... - Google Patents</title><script>(function(){(function(){function e(a){this.t={};this.tick=function(a,c,b){var d=void 0!=b?b:(new Date).getTime();this.t[a]=[d,c];if(void 0==b)try{window.console.timeStamp("CSI/"+a)}catch(e){}};this.tick("start",null,a)}var a;window.performance&&(a=window.performance.timing);var f=a?new e(a.responseStart):new e;window.jstiming={Timer:e,load:f};if(a){var c=a.navigationStart,d=a.responseStart;0<c&&d>=c&&(window.jstiming.srt=d-c)}if(a){var b=window.jstiming.load;0<c&&d>=c&&(b.tick("_wtsrt",void 0,c),b.tick("wtsrt_",
"_wtsrt",d),b.tick("tbsd_","wtsrt_"))}try{a=null,window.chrome&&window.chrome.csi&&(a=Math.floor(window.chrome.csi().pageT),b&&0<c&&(b.tick("_tbnd",void 0,window.chrome.csi().startE),b.tick("tbnd_","_tbnd",c))),null==a&&window.gtbExternal&&(a=window.gtbExternal.pageT()),null==a&&window.external&&(a=window.external.pageT,b&&0<c&&(b.tick("_tbnd",void 0,window.external.startE),b.tick("tbnd_","_tbnd",c))),a&&(window.jstiming.pt=a)}catch(g){}})();})();
</script><link rel="stylesheet" href="/patents/css/_8a2b04e7bf975d5171d8e4c0b6365c7a/kl_intl_patents_bundle.css" type="text/css" /><script src="/books/javascript/atb_8a2b04e7bf975d5171d8e4c0b6365c7a__en.js"></script><script>function googleTranslateElementInit() {new google.translate.TranslateElement({pageLanguage: "en",gaTrack: true,gaId: "UA-27188110-1",multilanguagePage: true});}</script><script src="//translate.google.com/translate_a/element.js?cb=googleTranslateElementInit"></script><meta name="DC.type" content="Patent"><meta name="DC.title" content="Method for in vitro cell growth of eucaryotic cells using low molecular weight peptides"><meta name="DC.contributor" content="Wim R. Blom" scheme="inventor"><meta name="DC.contributor" content="Anthonie Kunst" scheme="inventor"><meta name="DC.contributor" content="Bart J. van Schie" scheme="inventor"><meta name="DC.contributor" content="Gregory W. Luli" scheme="inventor"><meta name="DC.contributor" content="Quest International Flavors &amp; Food Ingredients Company, Division Of Indopco, Inc." scheme="assignee"><meta name="DC.date" content="1995-2-23" scheme="dateSubmitted"><meta name="DC.description" content="A method and kit for growing eucaryotic cells using a hydrolyzate of a protein material containing peptides and free amino acids. The material contains L-glutamine, preferably in an amount of greater than 20 percent by weight. Ninety percent by weight of the mixture is less than 1,000 kD in molecular weight. The free amino acid level is less than 20 percent by weight and the average peptide length is less than 20 amino acids."><meta name="DC.date" content="1998-4-21" scheme="issued"><meta name="DC.relation" content="EP:0220379:A1" scheme="references"><meta name="DC.relation" content="JP:H0249579" scheme="references"><meta name="DC.relation" content="JP:H0418769" scheme="references"><meta name="DC.relation" content="JP:H05236909" scheme="references"><meta name="DC.relation" content="US:3579423" scheme="references"><meta name="DC.relation" content="US:3852479" scheme="references"><meta name="DC.relation" content="US:3932671" scheme="references"><meta name="DC.relation" content="US:4058512" scheme="references"><meta name="DC.relation" content="US:4100151" scheme="references"><meta name="DC.relation" content="US:4235772" scheme="references"><meta name="citation_reference" content="Animal Cell Culture, A Practical Approach, Second Edition, ISBN 0 19 963213 8."><meta name="citation_reference" content="Animal Cell Culture, A Practical Approach, Second Edition, ISBN 0-19-963213-8."><meta name="citation_reference" content="Babcock et al. &quot;J. of Nutrition&quot;, v. 93, #3, Nov. 1967 pp. 368-376."><meta name="citation_reference" content="Babcock et al. J. of Nutrition , v. 93, 3, Nov. 1967 pp. 368 376."><meta name="citation_reference" content="Belitz, H.P. et al, p. 285 297, plus eng. transl., source unknown, 1982."><meta name="citation_reference" content="Belitz, H.P. et al, p. 285-297, plus eng. transl., source unknown, 1982."><meta name="citation_reference" content="Brand, K., et al., Metabolism 38:29 33 (1989)."><meta name="citation_reference" content="Brand, K., et al., Metabolism 38:29-33 (1989)."><meta name="citation_reference" content="Heeneman et al, J. Immunological Methods, 116, 85 91 (1991)."><meta name="citation_reference" content="Heeneman et al, J. Immunological Methods, 116, 85-91 (1991)."><meta name="citation_reference" content="Ishii, K. et al., J. of Household Soc. of Japan, v. 45(9), pp. 791 796, plus eng. tranl., 1994."><meta name="citation_reference" content="Ishii, K. et al., J. of Household Soc. of Japan, v. 45(9), pp. 791-796, plus eng. tranl., 1994."><meta name="citation_reference" content="MacRitchie, J. Food Technol. 14, 595, 601 (1979)."><meta name="citation_reference" content="Nedelkovits, J. et al., Food Investigation Gazette, v. 16(4 5) pp. 211 216, plus eng. transl. 1970."><meta name="citation_reference" content="Nedelkovits, J. et al., Food Investigation Gazette, v. 16(4-5) pp. 211-216, plus eng. transl. 1970."><meta name="citation_reference" content="Tenabe et al., Journal of Food Biochemistry, 16:235 248 (1993)."><meta name="citation_reference" content="Tenabe et al., Journal of Food Biochemistry, 16:235-248 (1993)."><meta name="citation_reference" content="Yoong et al &quot;Food Chem.&quot; v. 51 #2, 1994, pp. 271-274."><meta name="citation_reference" content="Yoong et al Food Chem. v. 51 2, 1994, pp. 271 274."><meta name="citation_patent_number" content="US:5741705"><meta name="citation_patent_application_number" content="US:08/393,338"><link rel="canonical" href="http://www.google.com/patents/US5741705"/><meta property="og:url" content="http://www.google.com/patents/US5741705"/><meta name="title" content="Patent US5741705 - Method for in vitro cell growth of eucaryotic cells using low molecular weight peptides"/><meta name="description" content="A method and kit for growing eucaryotic cells using a hydrolyzate of a protein material containing peptides and free amino acids. The material contains L-glutamine, preferably in an amount of greater than 20 percent by weight. Ninety percent by weight of the mixture is less than 1,000 kD in molecular weight. The free amino acid level is less than 20 percent by weight and the average peptide length is less than 20 amino acids."/><meta property="og:title" content="Patent US5741705 - Method for in vitro cell growth of eucaryotic cells using low molecular weight peptides"/><meta property="og:type" content="book"/><meta property="og:site_name" content="Google Books"/><meta property="og:image" content="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"/><link rel="image_src" href="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"/><script>(function(){try{var aa=function(a,b,c,d){d=d||{};d._sn=["cfg",b,c].join(".");window.gbar.logger.ml(a,d)};var g=window.gbar=window.gbar||{},l=window.gbar.i=window.gbar.i||{},m={},n;function _tvn(a,b){var c=parseInt(a,10);return isNaN(c)?b:c}function _tvf(a,b){var c=parseFloat(a);return isNaN(c)?b:c}function _tvv(a){return!!a}function p(a,b,c){(c||g)[a]=b}g.bv={n:_tvn("2",0),r:"",f:".67.",e:"0",m:_tvn("0",1)};
function q(a,b,c){var d="on"+b;if(a.addEventListener)a.addEventListener(b,c,!1);else if(a.attachEvent)a.attachEvent(d,c);else{var f=a[d];a[d]=function(){var a=f.apply(this,arguments),b=c.apply(this,arguments);return void 0==a?b:void 0==b?a:b&&a}}}var s=function(a){return function(){return g.bv.m==a}},ba=s(1),ca=s(2);p("sb",ba);p("kn",ca);l.a=_tvv;l.b=_tvf;l.c=_tvn;l.i=aa;var da=window.gbar.i.i;var t,u,v,w;function ea(a){v=a}function fa(a){var b;if(b=v&&window.encodeURIComponent)b=a.href,b=!b.match(/^http[s]?:\/\/accounts\.google\.[^/]*\/ClearSID/i)&&!b.match(/^http[s]?:\/\/[^/]*\/accounts\/ClearSID/i);if(b=b&&encodeURIComponent(v()))a.href=a.href.replace(/([?&]continue=)[^&]*/,"$1"+b)}function ga(a){window.gApplication&&(a.href=window.gApplication.getTabUrl(a.href))}
function ha(a){var b=document.forms[0].q,c=window.encodeURIComponent&&b&&b.value,b=b&&b.placeholder;c&&c!=b&&(a.href=a.href.replace(/([?&])q=[^&]*|$/,function(a,b){return(b||"&")+"q="+encodeURIComponent(c)}))}n=l.a("")?ga:ha;
function x(a,b,c,d,f,e){var h=document.getElementById(a);if(h){var k=h.style;k.left=d?"auto":b+"px";k.right=d?b+"px":"auto";k.top=c+"px";k.visibility=u?"hidden":"visible";f&&e?(k.width=f+"px",k.height=e+"px"):(x(t,b,c,d,h.offsetWidth,h.offsetHeight),u=u?"":a)}}
var y=[],ia=function(a,b){y.push(b)},ja=function(a){a=a||window.event;var b=a.target||a.srcElement;a.cancelBubble=!0;null==t&&(a=document.createElement(Array.every||window.createPopup?"iframe":"div"),a.frameBorder="0",t=a.id="gbs",a.src="javascript:''",b.parentNode.appendChild(a),q(document,"click",z));var c=b,b=0;"gb3"!=c.className&&(c=c.parentNode);a=c.getAttribute("aria-owns")||"gbi";var d=c.offsetWidth,f=20<c.offsetTop?46:24;document.getElementById("tphdr")&&(f-=3);var e=!1;do b+=c.offsetLeft||
0;while(c=c.offsetParent);var c=(document.documentElement.clientWidth||document.body.clientWidth)-b-d,h,d=document.body,k=document.defaultView;k&&k.getComputedStyle?(d=k.getComputedStyle(d,""))&&(h=d.direction):h=d.currentStyle?d.currentStyle.direction:d.style.direction;h="rtl"==h;if("gbi"==a){for(d=0;k=y[d++];)k();A(null,window.navExtra);h&&(b=c,e=!0)}else h||(b=c,e=!0);u!=a&&z();x(a,b,f,e)},z=function(){u&&x(u,0,0)},A=function(a,b){var c,d=document.getElementById("gbi"),f=a;f||(f=d.firstChild);
for(;b&&(c=b.pop());){var e=d,h=c,k=f;w||(w="gb2");e.insertBefore(h,k).className=w}},ka=function(a,b,c){if((b=document.getElementById(b))&&a){a.className="gb4";var d=document.createElement("span");d.appendChild(a);d.appendChild(document.createTextNode(" | "));d.id=c;b.appendChild(d)}},la=function(){return document.getElementById("gb_70")},ma=function(){return!!u};p("qs",n);p("setContinueCb",ea);p("pc",fa);p("tg",ja);p("close",z);p("addLink",ka);p("almm",A);p("si",la);p("adh",ia);p("op",ma);var B=function(){},C=function(){},F=function(a){var b=new Image,c=D;b.onerror=b.onload=b.onabort=function(){try{delete E[c]}catch(a){}};E[c]=b;b.src=a;D=c+1},E=[],D=0;p("logger",{il:C,ml:B,log:F});var G=window.gbar.logger;var H={},na={},I=[],oa=l.b("0.1",.1),pa=l.a("1",!0),qa=function(a,b){I.push([a,b])},ra=function(a,b){H[a]=b},sa=function(a){return a in H},J={},K=function(a,b){J[a]||(J[a]=[]);J[a].push(b)},ta=function(a){K("m",a)},L=function(a,b){var c=document.createElement("script");c.src=a;c.async=pa;Math.random()<oa&&(c.onerror=function(){c.onerror=null;B(Error("Bundle load failed: name="+(b||"UNK")+" url="+a))});(document.getElementById("xjsc")||document.getElementsByTagName("body")[0]||
document.getElementsByTagName("head")[0]).appendChild(c)},N=function(a){for(var b=0,c;(c=I[b])&&c[0]!=a;++b);!c||c[1].l||c[1].s||(c[1].s=!0,M(2,a),c[1].url&&L(c[1].url,a),c[1].libs&&m.d&&m.d(c[1].libs))},O=function(a){K("gc",a)},P=null,ua=function(a){P=a},M=function(a,b,c){if(P){a={t:a,b:b};if(c)for(var d in c)a[d]=c[d];try{P(a)}catch(f){}}};p("mdc",H);p("mdi",na);p("bnc",I);p("qGC",O);p("qm",ta);p("qd",J);p("lb",N);p("mcf",ra);p("bcf",qa);p("aq",K);p("mdd","");p("has",sa);
p("trh",ua);p("tev",M);var Q=l.b("0.1",.001),R=0;
function _mlToken(a,b){try{if(1>R){R++;var c,d=a,f=b||{},e=encodeURIComponent,h=["//www.google.com/gen_204?atyp=i&zx=",(new Date).getTime(),"&jexpid=",e("17483"),"&srcpg=",e("prop=22"),"&jsr=",Math.round(1/Q),"&ogev=",e("MoftU_r1LNPJsQTqt4DAAg"),"&ogf=",g.bv.f,"&ogrp=",e("1"),"&ogv=",e("1407723702.0"),"&oggv="+e("es_plusone_gc_20140723.0_p0"),"&ogd=",e("com"),"&ogc=",e("GBR"),"&ogl=",e("en")];f._sn&&(f._sn="og."+
f._sn);for(var k in f)h.push("&"),h.push(e(k)),h.push("="),h.push(e(f[k]));h.push("&emsg=");h.push(e(d.name+":"+d.message));var r=h.join("");S(r)&&(r=r.substr(0,2E3));c=r;var Aa=window.gbar.logger._aem(a,c);F(Aa)}}catch(Na){}}var S=function(a){return 2E3<=a.length},va=function(a,b){return b};function T(a){B=a;p("_itl",S,G);p("_aem",va,G);p("ml",B,G);a={};H.er=a}l.a("")?T(function(a){throw a;}):l.a("1")&&Math.random()<Q&&T(_mlToken);I.push(["m",{url:"//ssl.gstatic.com/gb/js/scm_7385cc5883250b43a39405734c1bea59.js"}]);g.mcf("c",{});g.sg={c:""};if(l.a("1")){var wa=l.a("");I.push(["gc",{auto:wa,url:"//ssl.gstatic.com/gb/js/abc/gci_91f30755d6a6b787dcc2a4062e6e9824.js",libs:"googleapis.client:plusone:gapi.iframes"}]);var xa={version:"gci_91f30755d6a6b787dcc2a4062e6e9824.js",index:"",lang:"en"};H.gc=xa;var U=function(a){window.googleapis&&window.iframes?a&&a():(a&&O(a),N("gc"))};p("lGC",U);l.a("1")&&p("lPWF",U)};window.__PVT="";if(l.a("1")&&l.a("1")){var V=function(a){U(function(){K("pw",a);N("pw")})};p("lPW",V);I.push(["pw",{url:"//ssl.gstatic.com/gb/js/abc/pwm_45f73e4df07a0e388b0fa1f3d30e7280.js"}]);var W=[],ya=function(a){W[0]=a},za=function(a,b){var c=b||{};c._sn="pw";B(a,c)},Ba={signed:W,elog:za,base:"https://plusone.google.com/u/0",loadTime:(new Date).getTime()};H.pw=Ba;var X=function(a,b){for(var c=b.split("."),d=function(){var b=arguments;a(function(){for(var a=g,d=0,e=c.length-1;d<e;++d)a=a[c[d]];a[c[d]].apply(a,b)})},f=g,e=0,h=c.length-1;e<h;++e)f=
f[c[e]]=f[c[e]]||{};return f[c[e]]=d};X(V,"pw.clk");X(V,"pw.hvr");p("su",ya,g.pw)};function Ca(){function a(){for(var b;(b=e[h++])&&"m"!=b[0]&&!b[1].auto;);b&&(M(2,b[0]),b[1].url&&L(b[1].url,b[0]),b[1].libs&&m.d&&m.d(b[1].libs));h<e.length&&setTimeout(a,0)}function b(){0<f--?setTimeout(b,0):a()}var c=l.a("1"),d=l.a(""),f=3,e=I,h=0,k=window.gbarOnReady;if(k)try{k()}catch(r){da(r,"ml","or")}d?p("ldb",a):c?q(window,"load",b):b()}p("rdl",Ca);var Da={D:1,H:2,da:3,p:4,W:5,M:6,F:7,g:8,ha:9,U:10,L:11,T:12,S:13,N:14,Q:15,P:16,fa:17,w:18,O:19,ga:20,ea:21,u:22,G:23,ja:24,ka:25,ia:26,A:27,j:28,o:29,k:30,ca:31,Z:32,$:33,J:34,K:35,ba:36,aa:37,Y:38,B:39,R:40,v:41,X:42,V:43,h:48,C:49,I:500},Y=[1,2,3,4,5,6,9,10,11,13,14,28,29,30,34,35,37,38,39,40,41,42,43,48,49,500];var Z=l.b("0.001",1E-4),Ea=l.b("1",1),Fa=!1,Ga=!1;if(l.a("1")){var Ha=Math.random();Ha<=Z&&(Fa=!0);Ha<=Ea&&(Ga=!0)}var Ia=Da,$=null;function Ja(){var a=0,b=function(b,d){l.a(d)&&(a|=b)};b(1,"");b(2,"");b(4,"");b(8,"");return a}
function Ka(a,b){var c=Z,d=Fa,f;f=a;if(!$){$={};for(var e=0;e<Y.length;e++){var h=Y[e];$[h]=!0}}if(f=!!$[f])c=Ea,d=Ga;if(d){d=encodeURIComponent;g.rp?(f=g.rp(),f="-1"!=f?f:"1"):f="1";c=["//www.google.com/gen_204?atyp=i&zx=",(new Date).getTime(),"&oge=",a,"&ogex=",d("17483"),"&ogev=",d("MoftU_r1LNPJsQTqt4DAAg"),"&ogf=",g.bv.f,"&ogp=",d("22"),"&ogrp=",d(f),"&ogsr=",Math.round(1/c),"&ogv=",d("1407723702.0"),"&oggv="+
d("es_plusone_gc_20140723.0_p0"),"&ogd=",d("com"),"&ogl=",d("en"),"&ogc=",d("GBR"),"&ogus=",Ja()];if(b){"ogw"in b&&(c.push("&ogw="+b.ogw),delete b.ogw);var k;f=b;e=[];for(k in f)0!=e.length&&e.push(","),e.push(La(k)),e.push("."),e.push(La(f[k]));k=e.join("");""!=k&&(c.push("&ogad="),c.push(d(k)))}F(c.join(""))}}function La(a){"number"==typeof a&&(a+="");return"string"==typeof a?a.replace(".","%2E").replace(",","%2C"):a}C=Ka;p("il",C,G);var Ma={};H.il=Ma;setTimeout(function(){C(Ia.g)},0);}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{var b=window.gbar.i.i;var c=window.gbar;var f=function(d){try{var a=document.getElementById("gbom");a&&d.appendChild(a.cloneNode(!0))}catch(e){b(e,"omas","aomc")}};c.aomc=f;}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{var a=window.gbar;a.mcf("pm",{p:""});}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{window.gbar.rdl();}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
if (window['_OC_timingAction']) {window['_OC_timingAction']('patents_refpage');}</script><style>#gbar,#guser{font-size:13px;padding-top:1px !important;}#gbar{float:left;height:22px}#guser{padding-bottom:7px !important;text-align:right}.gbh,.gbd{border-top:1px solid #c9d7f1;font-size:1px}.gbh{height:0;position:absolute;top:24px;width:100%}#gbs,.gbm{background:#fff;left:0;position:absolute;text-align:left;visibility:hidden;z-index:1000}.gbm{border:1px solid;border-color:#c9d7f1 #36c #36c #a2bae7;z-index:1001}.gb1{margin-right:.5em}.gb1,.gb3{zoom:1}.gb2{display:block;padding:.2em .5em}.gb2,.gb3{text-decoration:none !important;border-bottom:none}a.gb1,a.gb4{text-decoration:underline !important}a.gb1,a.gb2,a.gb3,a.gb4{color:#00c !important}.gbi .gb3,.gbi .gb2,.gbi .gb4{color:#dd8e27 !important}.gbf .gb3,.gbf .gb2,.gbf .gb4{color:#900 !important}a.gb2:hover{background:#36c;color:#fff !important}#gbar .gbz0l{color:#000 !important;cursor:default;font-weight:bold;text-decoration:none !important}
#gbar { padding:.3em .6em !important;}</style></head><body  topmargin="3" marginheight="3"><div id=gbar><nobr><a onclick=gbar.qs(this);gbar.logger.il(1,{t:1}); class=gb1 id=gb_1 href="https://www.google.com/search?sa=N&tab=tw">Search</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:2}); class=gb1 id=gb_2 href="http://www.google.com/search?hl=en&tbm=isch&source=og&sa=N&tab=ti">Images</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:8}); class=gb1 id=gb_8 href="http://maps.google.com/maps?hl=en&sa=N&tab=tl">Maps</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:78}); class=gb1 id=gb_78 href="https://play.google.com/?hl=en&sa=N&tab=t8">Play</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:36}); class=gb1 id=gb_36 href="http://www.youtube.com/results?sa=N&tab=t1">YouTube</a> <a onclick=gbar.logger.il(1,{t:5}); class=gb1 id=gb_5 href="http://news.google.com/nwshp?hl=en&tab=tn">News</a> <a onclick=gbar.logger.il(1,{t:23}); class=gb1 id=gb_23 href="https://mail.google.com/mail/?tab=tm">Gmail</a> <a onclick=gbar.logger.il(1,{t:25}); class=gb1 id=gb_25 href="https://drive.google.com/?tab=to">Drive</a> <a class=gb3 href="http://www.google.com/intl/en/options/" onclick="this.blur();gbar.tg(event);return !1" aria-haspopup=true><u>More</u> <small>&#9660;</small></a><div class=gbm id=gbi><a onclick=gbar.logger.il(1,{t:24}); class=gb2 id=gb_24 href="https://www.google.com/calendar?tab=tc">Calendar</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:51}); class=gb2 id=gb_51 href="http://translate.google.com/?hl=en&sa=N&tab=tT">Translate</a><a onclick=gbar.logger.il(1,{t:17}); class=gb2 id=gb_17 href="http://www.google.com/mobile/?hl=en&tab=tD">Mobile</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:10}); class=gb2 id=gb_10 href="http://www.google.com/search?hl=en&tbo=u&tbm=bks&source=og&sa=N&tab=tp">Books</a><a onclick=gbar.logger.il(1,{t:212}); class=gb2 id=gb_212 href="https://wallet.google.com/manage/?tab=ta">Wallet</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:6}); class=gb2 id=gb_6 href="http://www.google.com/search?hl=en&tbo=u&tbm=shop&source=og&sa=N&tab=tf">Shopping</a><a onclick=gbar.logger.il(1,{t:30}); class=gb2 id=gb_30 href="http://www.blogger.com/?tab=tj">Blogger</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:27}); class=gb2 id=gb_27 href="http://www.google.com/finance?sa=N&tab=te">Finance</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:31}); class=gb2 id=gb_31 href="https://plus.google.com/photos?sa=N&tab=tq">Photos</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:12}); class=gb2 id=gb_12 href="http://www.google.com/search?hl=en&tbo=u&tbm=vid&source=og&sa=N&tab=tv">Videos</a><div class=gb2><div class=gbd></div></div><a onclick=gbar.logger.il(1,{t:66}); href="http://www.google.com/intl/en/options/" class=gb2>Even more &raquo;</a></div></nobr></div><div id=guser width=100%><nobr><span id=gbn class=gbi></span><span id=gbf class=gbf></span><span id=gbe></span><a target=_top id=gb_70 href="https://www.google.com/accounts/Login?service=&continue=http://www.google.com/patents%3Fhl%3Den&hl=en" class=gb4>Sign in</a><div style="display: none"><div class=gbm id=gbd5 aria-owner=gbg5><div class=gbmc><ol id=gbom class=gbmcc></ol></div></div></div></nobr></div><div class=gbh style=left:0></div><div class=gbh style=right:0></div><div role="alert" style="position: absolute; left: 0; right: 0;"><a href="http://www.google.com/patents/us5741705?hl=en&amp;output=html_text" title="Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader."><img border="0" src="http://www.google.com/images/cleardot.gif"alt="Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader."></a></div><div id="guser"><nobr></nobr></div><div style="clear:both;"></div><div id="gb-top-search-box" class="gb-top-search-box-small gb-reset"><table><tr><td class="logo"><a href="http://www.google.com/patents" class="logo-link"><img class="logo-img" src="/intl/en/images/logos/google_logo_41.png" alt="Go to Google Books Home" height="41"/></a></td><td><form action="http://www.google.com/search" name="f" id="vheadf" method="get"><span id="hf"></span><input type="hidden" name="tbm" value="pts"/><input type="hidden" name="tbo" value="1"/><input type="hidden" name="hl" value="en"/><table><tr><td><div class="inputs"><table><tr><td><div class="text-input"><input type="text" name="q" id="vheadq" class="text" maxlength="2048" size="31" value="" title="Search Patents" accesskey="s" autocomplete="off"/><script>window._OC_autoDir &&window._OC_autoDir('vheadq', 'tia-vheadq');</script></div></td><td><div class="submit-input"><input name="btnG" class="submit" type="submit" value=""/></div></td></tr></table></div></td><td class="col-ext-links"><div class="ext-links"><a href="http://www.google.com/advanced_patent_search">&lt;nobr&gt;Advanced Patent Search&lt;/nobr&gt;</a></div></td></tr></table></form></td></tr></table></div><div class="kd-appbar"><h2 class="kd-appname"><a href="/patents">Patents</a></h2><div class="kd-buttonbar left" id="left-toolbar-buttons"><a id="appbar-write-review-link" href=""></a><a id="appbar-view-print-sample-link" href=""></a><a id="appbar-view-ebook-sample-link" href=""></a><a id="appbar-patents-prior-art-finder-link" href="https://www.google.com/patents/related/US5741705"></a><a id="appbar-patents-discuss-this-link" href="http://www.google.com/url?id=rsNFBAABERAJ&amp;q=http://patents.stackexchange.com/redirect/google-patents%3Fpatent%3DUS5741705&amp;usg=AFQjCNFWDYOYKK1ZySfQ9zbYdfIu2guA_w" data-is-grant="true"></a><a id="appbar-read-patent-link" href="//docs.google.com/viewer?url=patentimages.storage.googleapis.com/pdfs/US5741705.pdf"></a><a id="appbar-download-pdf-link" href="//patentimages.storage.googleapis.com/pdfs/US5741705.pdf"></a></div><div class="kd-buttonbar right" id="right-toolbar-buttons"></div></div><div id="books-microdata" itemscope=""itemtype="http://schema.org/Book"itemid="http://www.google.com/patents/US5741705" style="display:none"><span itemprop="description">A method and kit for growing eucaryotic cells using a hydrolyzate of a protein material containing peptides and free amino acids. The material contains L-glutamine, preferably in an amount of greater than 20 percent by weight. Ninety percent by weight of the mixture is less than 1,000 kD in molecular...</span><span itemprop="url">http://www.google.com/patents/US5741705?utm_source=gb-gplus-share</span><span class="main-title" itemprop="name">Patent US5741705 - Method for in vitro cell growth of eucaryotic cells using low molecular weight peptides</span><img itemprop="image" src="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"alt="Patent US5741705 - Method for in vitro cell growth of eucaryotic cells using low molecular weight peptides" title="Patent US5741705 - Method for in vitro cell growth of eucaryotic cells using low molecular weight peptides"></div><div style="display: none"><ol id="ofe-gear-menu-contents" class="gbmcc"><li class="gbe gbmtc"><a class="gbmt goog-menuitem-content" id="" href="http://www.google.com/advanced_patent_search">Advanced Patent Search</a></li></ol></div><table id="viewport_table" cellpadding="0" style="clear:both" cellspacing="0"><tr><td id="viewport_td"><div class=vertical_module_list_row><div id=intl_patents class=about_content><div id=intl_patents_v><table class="patent-bibdata"><tr><td class="patent-bibdata-heading">Publication number</td><td class="single-patent-bibdata">US5741705 A</td></tr><tr><td class="patent-bibdata-heading">Publication type</td><td class="single-patent-bibdata">Grant</td></tr><tr><td class="patent-bibdata-heading">Application number</td><td class="single-patent-bibdata">US 08/393,338</td></tr><tr><td class="patent-bibdata-heading">Publication date</td><td class="single-patent-bibdata">Apr 21, 1998</td></tr><tr><td class="patent-bibdata-heading">Filing date</td><td class="single-patent-bibdata">Feb 23, 1995</td></tr><tr><td class="patent-bibdata-heading">Priority date<span class="patent-tooltip-anchor patent-question-icon"data-tooltip-text="The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed."></span></td><td class="single-patent-bibdata">Feb 23, 1995</td></tr><tr><td class="patent-bibdata-heading">Fee status<span class="patent-tooltip-anchor patent-question-icon"data-tooltip-text="The fee status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status or dates listed."></span></td><td class="single-patent-bibdata">Paid</td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Also published as</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="/patents/US5885835">US5885835</a></span></span></td></tr><tr class="patent-bibdata-list-row alternate-patent-number"><td class="patent-bibdata-heading">Publication number</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value">08393338, </span><span class="patent-bibdata-value">393338, </span><span class="patent-bibdata-value">US 5741705 A, </span><span class="patent-bibdata-value">US 5741705A, </span><span class="patent-bibdata-value">US-A-5741705, </span><span class="patent-bibdata-value">US5741705 A, </span><span class="patent-bibdata-value">US5741705A</span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Inventors</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Wim+R.+Blom%22">Wim R. Blom</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Anthonie+Kunst%22">Anthonie Kunst</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Bart+J.+van+Schie%22">Bart J. van Schie</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Gregory+W.+Luli%22">Gregory W. Luli</a></span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Original Assignee</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=inassignee:%22Quest+International+Flavors+%26+Food+Ingredients+Company,+Division+Of+Indopco,+Inc.%22">Quest International Flavors & Food Ingredients Company, Division Of Indopco, Inc.</a></span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Export Citation</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="/patents/US5741705.bibtex">BiBTeX</a>, </span><span class="patent-bibdata-value"><a href="/patents/US5741705.enw">EndNote</a>, </span><span class="patent-bibdata-value"><a href="/patents/US5741705.ris">RefMan</a></span></span></td></tr><tr class="patent-internal-links"><td colspan=2><span class="patent-bibdata-value"><a href="#backward-citations">Patent Citations</a> (10),</span> <span class="patent-bibdata-value"><a href="#npl-citations">Non-Patent Citations</a> (19),</span> <span class="patent-bibdata-value"><a href="#forward-citations">Referenced by</a> (29),</span> <span class="patent-bibdata-value"><a href="#classifications">Classifications</a> (8),</span> <span class="patent-bibdata-value"><a href="#legal-events">Legal Events</a> (7)</span> </td></tr><tr><td colspan=2 class="patent-bibdata-external-link-spacer-top"></td></tr><tr class="patent-bibdata-external-link-spacer-bottom"></tr><tr><td colspan=2><span class="patent-bibdata-heading">External Links:&nbsp;</span><span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=rsNFBAABERAJ&q=http://patft.uspto.gov/netacgi/nph-Parser%3FSect2%3DPTO1%26Sect2%3DHITOFF%26p%3D1%26u%3D/netahtml/PTO/search-bool.html%26r%3D1%26f%3DG%26l%3D50%26d%3DPALL%26RefSrch%3Dyes%26Query%3DPN/5741705&usg=AFQjCNGcQlTIAE-v1OyBIQbkGj6FfqtNYA">USPTO</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=rsNFBAABERAJ&q=http://assignments.uspto.gov/assignments/q%3Fdb%3Dpat%26pat%3D5741705&usg=AFQjCNEAfmgXSN3bL-8dR3v5cJV-M9ucjg">USPTO Assignment</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=rsNFBAABERAJ&q=http://worldwide.espacenet.com/publicationDetails/biblio%3FCC%3DUS%26NR%3D5741705A%26KC%3DA%26FT%3DD&usg=AFQjCNGU8dse8vXk-pIf-2pEZK4tSkpBjA">Espacenet</a></span></span></td></tr><tr class="patent-bibdata-group-spacer"></tr></table><div class="number-and-title"><span class="patent-title"><invention-title mxw-id="PT54272025" lang="EN" load-source="patent-office">Method for in vitro cell growth of eucaryotic cells using low molecular weight peptides</invention-title></span><br><span class="patent-number">US 5741705 A</span></div><div class="patent-section patent-abstract-section"><div class="patent-section-header"><span class="patent-section-title">Abstract</span></div><div class="patent-text"><abstract mxw-id="PA37750835" lang="EN" load-source="patent-office"> <div class="abstract">A method and kit for growing eucaryotic cells using a hydrolyzate of a protein material containing peptides and free amino acids. The material contains L-glutamine, preferably in an amount of greater than 20 percent by weight. Ninety percent by weight of the mixture is less than 1,000 kD in molecular weight. The free amino acid level is less than 20 percent by weight and the average peptide length is less than 20 amino acids.</div>
  </abstract></div></div><div class="patent-section patent-drawings-section"><div class="patent-section-header"><span class="patent-section-title">Images<span class="patent-section-count">(9)</span></span></div><div class="patent-drawings-body"><div class="patent-drawings-carousel"><div class="drawings"><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5741705-0.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5741705-0.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5741705-1.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5741705-1.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5741705-2.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5741705-2.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5741705-3.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5741705-3.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5741705-4.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5741705-4.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5741705-5.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5741705-5.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5741705-6.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5741705-6.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5741705-7.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5741705-7.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/pages/US5741705-8.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/pages/US5741705-8.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div></div></div><div class="patent-drawings-control patent-drawings-prev"><img class="patent-drawings-button-img" alt="Previous page"src="/googlebooks/images/kennedy/page_left.png"width="21" height="21" /></div><div class="patent-drawings-control patent-drawings-next"><img class="patent-drawings-button-img" alt="Next page"src="/googlebooks/images/kennedy/page_right.png"width="21" height="21" /></div></div></div><div class="patent-post-drawings"></div><div class="patent-section patent-claims-section"><div class="patent-section-header"><span class="patent-section-title">Claims<span class="patent-section-count">(19)</span></span></div><div class="patent-text"><div mxw-id="PCLM5214415" lang="EN" load-source="patent-office" class="claims">
    <claim-statement>We claim:</claim-statement> <div class="claim"> <div num="1" class="claim">
      <div class="claim-text">1. In a method for maintaining or growing eucaryotic cells in vitro requiring L-glutamine by use of a culture medium wherein the method includes culturing the cells in the culture medium, the improvement which comprises: providing a hydrolyzed protein material containing peptides as a mixture in the culture medium in an effective amount which provides a main source of the L-glutamine for the cells alone and as the peptides of at least 20% by weight of the hydrolyzed protein material, wherein the hydrolyzed protein material is obtained by enzymatic hydrolysis with an enzyme and any insoluble materials are separated from a hydrolysate and then the hydrolysate is subjected to membrane filtration, wherein the hydrolyzed protein material has a free amino acid level of less than about 15 percent of a total weight of the hydrolyzed protein material, has an average length of the peptides which is less than about 15 amino acids and contains greater than 90 percent by weight of the hydrolyzed protein material of the peptides and amino acids with a molecular weight of less than 1000 Daltons, as determined by gel permeation chromatography.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="2" class="claim">
      <div class="claim-text">2. The method of claim 1 wherein the hydrolyzed protein material has the molecular weight less than the 1000 Daltons, as a result of the membrane filtration.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="3" class="claim">
      <div class="claim-text">3. The method of any one of claims 1 or 2 wherein more than about 50 percent by weight of the effective amount of the L-glutamine is as a peptide.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="4" class="claim">
      <div class="claim-text">4. The method of any one of claims 1 or 2 wherein the free amino acid level is less than about 10 percent by weight of the hydrolyzed protein material and the length of the peptides is less than 10 amino acids.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="5" class="claim">
      <div class="claim-text">5. The method of any one of claims 1 or 2 wherein the hydrolyzed protein material is selected from the group consisting of casein, gluten, subfractions of gluten, milk protein, meat protein, soy protein, rice protein, potato protein, pea protein and maize protein.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="6" class="claim">
      <div class="claim-text">6. The method of any one of claims 1 or 2 wherein the mixture has a pH which allows the cells to be grown in the culture medium.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="7" class="claim">
      <div class="claim-text">7. The method of claim 6 wherein the pH of the mixture is between about 6 and 8.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="8" class="claim">
      <div class="claim-text">8. The method of any one of claims 1 or 2 wherein the cells are mammalian.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="9" class="claim">
      <div class="claim-text">9. The method of any one of claims 1 or 2 wherein the cells are human.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="10" class="claim">
      <div class="claim-text">10. The method of any one of claims 1 or 2 wherein the cells are insect.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="11" class="claim">
      <div class="claim-text">11. The method of any one of claims 1 or 2 wherein the mixture contains L-glutamine alone and as a peptide in an effective amount of at least 20 percent in the hydrolyzed protein material by weight, wherein more than about 50 percent by weight of the amount of L-glutamine is as a peptide with one or two amino acids, and wherein the free amino acid level is less than about 10 percent by weight of the total hydrolyzed protein material and the length of the peptides is less than 10 amino acids.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="12" class="claim">
      <div class="claim-text">12. The method of any one of claims 1 or 2 wherein the enzyme is a protease.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="13" class="claim">
      <div class="claim-text">13. The method of any one of claims 1 or 2 wherein the enzyme is a protease and the protein material is a gluten.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="14" class="claim">
      <div class="claim-text">14. The method of any one of claims 1 or 2 wherein the enzyme is a protease and the protein material is wheat gluten.</div>
    </div>
    </div> <div class="claim"> <div num="15" class="claim">
      <div class="claim-text">15. In a method for maintaining or growing eucaryotic cells in vitro requiring L-glutamine by use of a culture medium wherein the method includes culturing the cells in the culture medium, the improvement which comprises: adding to the culture medium in an effective amount which provides a main source of the L-glutamine for the cells alone and as peptides of at least 20% by weight of the hydrolyzed protein material a peptide mixture obtained by enzymatic hydrolysis of a protein material, which said peptide mixture has a free amino acid level of less than 15% by weight of the hydrolyzed protein material by weight of the peptide mixture, has an average chain length of the peptides of less than 15 amino acids, contains more than 90% of the total weight of the peptide mixture of peptides with a molecular weight of less than 1000 Daltons as determined by gel permeation chromatography.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="16" class="claim">
      <div class="claim-text">16. The method according to claim 15 wherein the hydrolyzed protein material has been subjected to a membrane filtration.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="17" class="claim">
      <div class="claim-text">17. The method according to claim 16 wherein the membrane has a molecular weight cut-off of 10,000 Daltons.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="18" class="claim">
      <div class="claim-text">18. The method according to any one of claims 15 or 16 wherein more than 50% by weight of the effective amount of L-gutamine is as a peptide.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="19" class="claim">
      <div class="claim-text">19. The method according to any one of claims 15 or 16 wherein to the culture medium is also added a amino acid selected from the group consisting of asparagine, arginine, cystine, lysine and hydroxyproline to compensate for a lack of these amino acids in peptide mixture for growing the cells.</div>
    </div>
  </div> </div></div></div><div class="patent-section patent-description-section"><div class="patent-section-header"><span class="patent-section-title">Description</span></div><div class="patent-text"><div mxw-id="PDES67103476" lang="EN" load-source="patent-office" class="description">
    <heading>BACKGROUND OF THE INVENTION</heading> <p>(1) Field of the Invention</p>
    <p>The present invention relates to a novel method and kit for proliferation, propagation, maintaining and culturing of eucaryotic cells. In particular the present invention relates to the use of a protein hydrolysate, prepared using one or more hydrolytic enzymes as a basis of a medium for eucaryotic cells.</p>
    <p>(2) Description of Related Art</p>
    <p>Existing media for eucaryotic cells (culture media) in general comprise mixtures of amino acids, vitamins, carbohydrates and minerals. Culture media contain relatively large amounts of the amino acid L-glutamine. Typically L-glutamine is used in a cell culture medium at a concentration of about 2 mM. L-glutamine is an important energy source in proliferating eucaryotic cells and it also serves as both a carbon and a nitrogen source, especially for purine and pyrimidine synthesis.</p>
    <p>The use of L-glutamine as an energy source in cultured mammalian cells proceeds via deamidation of L-glutamine by glutaminase to yield glutamate and ammonia. Glutamate then undergoes transamination to produce Î±-ketoglutaric acid which is incorporated into the energy yielding Krebbs tricarboxylic acid cycle.</p>
    <p>The incorporation of L-glutamine in a liquid cell culture medium however suffers from the disadvantage that L-glutamine is not stable in the free amino acid form. It is well known to those skilled in the art that it rapidly decomposes into ammonia and pyroglutamic acid. Recently Heeneman et al (J. Immunological methods, 116, 85-91 (1991)) found that as a consequence of this decomposition all tested commercial media contained significantly less L-glutamine than prescribed. In addition, Heeneman et al point to the fact that the formed ammonia can be toxic to cultured cells.</p>
    <p>When L-glutamine is incorporated in a peptide it does not decompose. It is stable provided that the L-glutamine residue is not present at the amino terminal side since at this position the L-glutamine residue can decompose into a pyroglutamic acid residue and ammonia. Peptide material containing L-glutamine residues can be obtained via the hydrolysis of suitable proteins or can be prepared synthetically.</p>
    <p>There is abundant prior art on the hydrolysis of protein but mainly the use in food products or the use in media to grow micro-organisms is described. In general two types of protein hydrolysates can be distinguished: (1) hydrolysates comprising peptides with a chain length above about 15 amino acids and a relatively low level of free amino acids (below 10%); and (2) hydrolysates comprising peptides with a chain length below 15 amino acids and a relatively high level of free amino acids (about 15% or more).</p>
    <p>Hydrolysates from the first group are in food applications mainly used as functional ingredients to aerate or emulsify. It is well known that for optimal functionality peptides with 15-50 amino acids residues are required. The presence of free amino acids should be avoided as these give an unwanted savory taste and smell to the product. Consequently these type of hydrolysates comprise peptides with a chain length well above 15 amino acids and a level of free amino acids below about 10%. To our knowledge hydrolysates from this group do not find an application in media to culture eucaryotic cells.</p>
    <p>Hydrolysates from the second group are in food applications mainly used in infant and clinical formulae where a low allergenicity is required. Another preferred characteristic of these products is a reduced bitterness. In both cases the product should contain small peptides and this is achieved via the use of enzyme preparations having both endo- and exo-peptidase activity. As a consequence of the action of the exopeptidases the amount of free amino acids is strongly increased to levels of about 15% or higher.</p>
    <p>In the fermentation industries only those hydrolysates from the second group are used which have high amounts of free amino acids (20% and preferably higher). In this case the hydrolysates are used as a relatively cheap source of free amino acids. Protein hydrolysates with a high level of free amino acids however also suffer from the disadvantage that the free glutamine decomposes into pyro-glutamic acid and the toxic ammonia and thus are not very well suited for application in cell culture media.</p>
    <p>The prior art (e.g. Animal Cell Culture, A practical approach, second edition, ISBN 0-19-963213-8) describes the use of lactalbumin hydrolysates (prepared with pancreatin which contains both endo- and exopeptidase activity) or other peptones (hydrolysates with a very high level of free amino acids) in cell tissue culture media, but only as supplements and not as the main source of glutamine or other amino acids.</p>
    <p>The application of synthetic peptides containing glutamine residues to our knowledge is commercially unattractive due to the very limited availability of such peptides and their relatively high price.</p>
    <p>To our knowledge there is no description in the prior art of the use in cell culture media of larger peptides (in the form of protein hydrolysates) or intact proteins containing glutamine residues as the main or only source of glutamine and other amino acids.</p>
    <heading>OBJECTS OF THE INVENTION</heading> <p>It is an object of the present invention to provide a novel method and kit for the in vitro culturing of eucaryotic cells. In particular, it is an object of the present invention to provide an economic source of L-glutamine which is stable in aqueous solution, to provide an economic source of other amino acids under the conditions used to culture eucaryotic cells, which is easy to use, can be sterilized by conventional means and is free of toxic and inhibitory effects. It is further an object to provide a method and kit which is inexpensive to produce. Numerous other objects will become increasingly apparent to those skilled in the art.</p>
    <heading>DESCRIPTION OF PREFERRED EMBODIMENTS</heading> <p>The present invention relates to a method for maintaining or growing eucaryotic cells in vitro requiring L-glutamine by use of a culture medium, the improvement which comprises: providing a hydrolysed protein material containing peptides including L-glutamine and amino acids in a mixture in the growth medium, wherein the mixture has a free amino acid level of less than about 15 percent by total proteinaceous material weight, has an average length of the peptide which is less than about 15 amino acids and contains greater than 90 percent by total proteinaceous material weight of the peptides and amino acids with a molecular weight of less than 1000 Dalton.</p>
    <p>Further the present invention relates to a kit for growing eucaryotic cells to be cultured which require L-glutamine for growth in vitro, the improvement which comprises: a separate container of a dry culture medium containing a hydrolysed protein material containing peptides including L-glutamine and amino acids in a mixture in the culture medium, wherein the mixture has a free amino acid level of less than about 15 percent by total proteinaceous material weight, has an average length of the peptide which is less than about 15 amino acids and contains greater than 90 percent by total proteinaceous material weight of the peptides and amino acids with a molecular weight of less than 1000 Dalton.</p>
    <p>Preferably the mixture contains the L-glutamine in an amount of at least 20 percent by total proteinaceous material weight. Also preferably, more than about 50 percent by weight of the amount of the L-glutamine is bound to one and two amino acids. Preferably the free amino acid level is less than about 10 percent by the total proteinaceous material weight and the length of the peptide is less than 10 amino acids.</p>
    <p>Also preferably the eucaryotic cells can be insect or mammalian cells, including human cells. Also preferably the pH is optimal for the cells. Also preferably the mixture has a pH between about 6 and 8.</p>
    <p>In particular, the present invention relates to a method for proliferation, propagation, maintaining and culturing of eucaryotic cells in vitro by the use of a culture medium which provides a mixture of small L-glutamine residue containing peptides as the main or only source of L-glutamine and other essential amino acids, characterized in that said mixture of peptides is obtained by a controlled enzymatic hydrolysis of a protein containing raw material.</p>
    <p>Higher eucaryotic cells in general lack the capacity of utilizing complex protein. It was thus unexpected that the hydrolyzed protein material from the present invention was able to support the culturing of eucaryotic cells. There is no clear explanation for this observation, but it may be hypothesized that eucaryotic cells apart from the sodium dependent amino acid uptake system (comprising a carrier protein) possess a mechanism via which small peptides can easily be transported into the cell.</p>
    <p>The protein raw material of the present invention can be of animal or plant origin, examples of such proteins are milk proteins, meat proteins, soy proteins, wheat proteins, rice proteins or maize proteins. Preferably the protein raw material is wheat gluten protein or a subfraction thereof such as gliadin or glutamine.</p>
    <p>The protein raw material is hydrolyzed by one or more hydrolytic enzymes. The hydrolytic enzyme can be of animal, plant, yeast bacterial or fungal origin. Preferably enzyme preparations are used which have a low exo-peptidase activity to minimize the liberation of free amino acids. Examples of such enzyme preparations are Pepsin, Alcalase or Orientase.</p>
    <p>The hydrolyzed protein material of the present invention is characterized by:</p>
    <p>a free amino acid level smaller than about 15% and</p>
    <p>an average peptide chain length smaller than about 15 amino acid residues.</p>
    <p>a molecular weight of the majority of the peptides in the hydrolysate preferably lower than 1000 Dalton.</p>
    <p>a level of glutamine residues in the hydrolyzed protein material preferably higher than 20%.</p>
    <p>Published data on the composition of commonly used cell culture media reveal that these in general contain high levels of L-glutamine. To provide a protein hydrolysate also containing high levels of L-glutamine wheat gluten or subfractions thereof such as gliadine or glutenine is the preferred protein raw material. It is well known to those skilled in the art that wheat gluten contains high levels of glutamine residues (about 25-30%).</p>
    <p>The analytical methods to determine the various relevant parameters are described below.</p>
    <heading>Analytical methods</heading> <p>Definitions</p>
    <p>TN: Total Nitrogen.</p>
    <p>AN: Alpha amino nitrogen.</p>
    <p>EN: Epsilon amino nitrogen.</p>
    <p>AEN: The sum of alpha and epsilon nitrogen.</p>
    <p>PN: Nitrogen in (potential) peptide bonds (PN thus includes all AN).</p>
    <p>FAA: Free amino acid level.</p>
    <p>F: average amount of nitrogen per amino acid residue in a protein.</p>
    <p>PCL: average peptide chain length.</p>
    <p>Determination of parameters</p>
    <p>AEN can be determined via well known methods, such as the TNBS method or via formaldehyde titration.</p>
    <p>TN can be determined via the well known Kjeldahl method.</p>
    <p>EN is only present in the side chain of lysine so it is equal to the amount of lysine in the product.</p>
    <p>FAA is determined using an amino acid analyzer.</p>
    <p>AN can be calculated from the AEN (as determined via TNBS or formaldehyde titration) and the amount of lys (=EN) in the protein hydrolysate.</p>
    <p>
      </p> <pre xml:space="preserve" listing-type="equation">AN=AEN=EN                                                  (1)</pre>
    
    <p>PN can be approximated from TN using the average amount of nitrogen (F) per amino acid.</p>
    <p>
      </p> <pre xml:space="preserve" listing-type="equation">PN=TN/F                                                    (2)</pre>
    
    <p>Most amino acids only have an alpha nitrogen atom but trp, lys, asn and gln have 1 extra nitrogen in the side chain, his has 2 extra nitrogen and arg has 3 extra nitrogen in the side chain.</p>
    <p>Calculation of the average peptide chain length</p>
    <p>The average peptide chain length can be calculated from AN and PN:</p>
    <p>
      </p> <pre xml:space="preserve" listing-type="equation">PCL=PN/AN                                                  (3)</pre>
    
    <p>Combining eq. 2 with eq. 3 gives:</p>
    <p>
      </p> <pre xml:space="preserve" listing-type="equation">PCL=TN/F*AN)                                               (4)</pre>
    
    <p>Combining eq. 4 with eq. 1 gives:</p>
    <p>
      </p> <pre xml:space="preserve" listing-type="equation">PCL=TN/(F*(AEN-EN)                                         (5)</pre>
    
    <p>With eq. 5 the average peptide length in a hydrolysate is calculated in which also the FAA is taken into account. Strictly spoken an amino acid is not a peptide and FAA thus should not be included in the calculation of the average PCL. To calculate the average peptide length of the non FAA fraction, TN and AN of this fraction are required. Rewriting eq. 4 for the peptide fraction gives:</p>
    <p>
      </p> <pre xml:space="preserve" listing-type="equation">PCL<sub>pep</sub> =TN<sub>pep</sub> /(F*AN<sub>pep</sub>)                    (6)</pre>
    
    <p>in which:</p>
    <p>
      </p> <pre xml:space="preserve" listing-type="equation">TN<sub>pep</sub> =TN-TN<sub>FAA</sub>                                  ( 7)</pre>
    
    <p>
      </p> <pre xml:space="preserve" listing-type="equation">TN<sub>FAA</sub> =F*FAA                                          (8)</pre>
    
    <p>
      </p> <pre xml:space="preserve" listing-type="equation">AN<sub>pep</sub> =AN-FAA                                         (9)</pre>
    
    <p>Combining eq. 6 with eq. 1, 7, 8 and 9 results in: ##EQU1## in which TN, AN, AEN, EN and FAA are given in mmol per weight unit. 2. Determination of molecular weight distribution</p>
    <p>There are a number of methods to determine the molecular weight distribution. An easy and convenient method uses gel permeation chromatography. There are many, all slightly different, procedures reported in the literature.</p>
    <p>The method referred to in this patent application uses a Protein-Pak 60 column from Waters with a length of 30 cm and an internal diameter of 7.8 mm and a Protein-Pak 125 Bulk Packing guard column. The column is eluted with a 0.1M potassium phosphate buffer with pH 7.0 at a flow rate of 1.0 ml/min. For analysis 20 Î¼l samples containing 0.2-0.5 mg product per ml elution buffer are injected on the column. Protein and peptide peaks are detected at 214 nm.</p>
    <p>The amount of material within a molecular weight range is determined from the area under the chromatogram in that molecular weight range.</p>
    <p>3. Determination of glutamine levels in protein hydrolysates</p>
    <p>Due to the instability of free L-glutamine it is not possible to determine the amount of L-glutamine in a protein based product via the normal procedure to determine the amino acid composition. In this procedure, the protein based product is treated with 6N HCl to hydrolyze it into free amino acids of which the amount can then be determined with an amino acid analyzer. During the 6N HCl hydrolysis glutamine decomposes into ammonia and pyroglutamate which is subsequently converted in glutamic acid.</p>
    <p>An indirect method to analyze the amount of L-glutamine in a hydrolysate is to determine the amount of NH<sub>3</sub> liberated during the acid hydrolysis as described by MacRitchie (J. Food Technol. 14, 595-601 (1979)). Since NH<sub>3</sub> is not only liberated from L-glutamine but also from asparagine (which decomposes into ammonia and aspartic acid) the amount of mmol NH<sub>3</sub> liberated from a protein sample equals the amount of mmol (L-glutamine+asparagine) in the protein sample. Since the origin of the liberated NH<sub>3</sub> cannot be determined it has to be assumed that the proportion of amidated groups is the same in the two types of chains.</p>
    <p>
      </p> <pre xml:space="preserve" listing-type="tabular">              TABLE 1______________________________________Determination of Gln levels.         Casein  Whey    Gluten______________________________________%TN             13.7      14.4    14.0mmol NH<sub>3</sub> (=mmol Asn + Gln)           100.0     73.8    211.8mmol Asx (analytical           49.9      80.2    18.2data)mmol Glx (analytical           140.7     128.1   239.1data)% (Asn + Gln)/(Asx + Glx)           52.5      35.4    77.3Analytical% (Asn + Gln)/(Asx + Glx)           50.1      38.3Amino acid sequence______________________________________</pre>
    
    <p>We have tested the reliability of this method by determination of the amount of NH<sub>3</sub> liberated from casein and whey protein and comparing the results with the theoretical results calculated on basis of the known compositions and amino acid sequences of the individual caseins and whey proteins.</p>
    <p>In addition the amount of NH<sub>3</sub> liberated from gluten was determined. The results are summarized in Table 2. It can be seen that there is a good agreement between the (Asn+Gln)/(Asx+Glx) ratio as determined experimentally from the analyzed amounts of liberated NH<sub>3</sub>, Glx and Asx and the ratio as it should theoretically be on basis of the amino acid composition. The experimentally determined ratio for gluten (77.3%) is in line with the ratio reported by MacRitchie (75.8%).</p>
    <p>From these results it is concluded that the determination of the amount of NH<sub>3</sub> liberated from a protein or a protein hydrolysate is a suitable method to assess the (Asn+Gln)/(Asx+Glx) ratio in a protein based product.</p>
    <p>The following are non-limiting examples of the present invention.</p>
    <heading>EXAMPLE 1</heading> <p>Production of a protein hydrolysate using vital gluten</p>
    <p>A 8% dispersion of vital gluten is hydrolyzed with 1% (E/S) of the commercially available enzyme preparation Quest neutral protease (ex Quest-Biocon, Cork, Ireland) at 50Â° C. for 4 hours. The pH is initially set at pH 7 and during the hydrolysis it is not controlled. After hydrolysis the enzyme is inactivated via a heat treatment of 95Â° C. for 1 minute. Residual intact protein and insoluble components are removed via centrifugation for 5 minutes at 2500 g and the obtained effluent is subsequently ultrafiltered. Preferably membranes with a molecular weight cutoff of 10,000 Dalton are used. The obtained ultrafiltration permeate is concentrated via evaporation and is then spray dried.</p>
    <p>The obtained final product is characterized using the above described methods. The results are summarized in Table 2.</p>
    <p>Evaluation of the hydrolysate in cell tissue cultures</p>
    <p>Three media were composed on basis of the well known RPMI-1640 medium. This medium was prepared as prescribed from the RPMI-1640 select Amine kit from Gibco BRL, Life Technologies Inc., Cat. No. 17402-017 (Glascow, Scotland). The medium was divided in three equal portions which were used as basis for medium 1, 2 and 3.</p>
    <p>To the media a supplement can be added. This supplement contains:</p>
    <p>L-glutamine: 2 mM</p>
    <p>Sodium pyruvate: 1 mM</p>
    <p>Gentamycin: 55 Î¼g/ml</p>
    <p>Î²-mercapto-ethanol : 50 Î¼M</p>
    <p>hypoxanthine: 100 Î¼M</p>
    <p>thymidine: 15 Î¼M</p>
    <p>fetal bovine serum: 8% (v/v)</p>
    <p>Medium 1</p>
    <p>To the basic RPMI-1640 medium obtained from the Gibco's select Amine kit the supplement was added. Medium 2.</p>
    <p>To the basic RPMI-1640 medium obtained from the Gibco's select Amine kit the supplement without the L-glutamine was added. Instead of L-glutamine as present in the supplement 2.2 g/l of the obtained gluten hydrolysate containing 3.4% free amino acids and 97.4% peptides having a molecular weight less than 1000 daltons as shown in Table 2 was added.</p>
    <p>Additionally the free amino acids asparagine, arginine, cystine, lysine and hydroxyproline are supplemented to compensate for the low levels of these amino acids in the obtained gluten hydrolysate. Medium 3.</p>
    <p>To the basic RPMI-1640 medium obtained from the Gibco's select Amine kit the supplement without the L-glutamine was added. Instead thereof 2.2 g/l of a mixture of free amino acids with the same composition as the obtained gluten hydrolysate was added.</p>
    <p>Additionally the free amino acids asparagine, arginine, cystine, lysine and hydroxyproline are supplemented to compensate for the low levels of these amino acids in the obtained gluten hydrolysate.</p>
    <p>
      </p> <pre xml:space="preserve" listing-type="tabular">              TABLE 2______________________________________Composition of the product obtained in Example 1______________________________________  % AN   1.57  % TN   14.80  % FAA  3.54  PCL    9.3  &gt;10 kD 0.1%  5-10 kD         0.1%  1-5 kD 2.4%  &lt;1 kD  97.4%______________________________________         Total Amino                   Free Amino Acids         Acids - mg/g                   mg/gAlanine       23.4      1.9Arginine      27.0      3.7Asparagine +  24.5      0.8Aspartic acidCysteine      9.0       2.1Glutamine +   279.7     3.2Glutamine acidGlycine       29.9      0.3Histidine     17.9      1.0Isoleucine    24.7      1.9Leucine       61.3      6.1Lysine        12.1      2.0Methionine    12.1      1.1Phenylalanine 43.4      3.1Proline       124.8     2.1Serine        50.6      1.2Threonine     24.0      0.8Tyrosine      28.5      0.4Valine        28.4      3.7______________________________________</pre>
    
    <p>
      </p> <pre xml:space="preserve" listing-type="tabular">              TABLE 3______________________________________Growth of three different cell lines on the formulated media. (Countsexpressed as cell per ml).                     after 1                            after 5                                   after 7Cell line   Medium   day 0    day    days   days______________________________________U266    medium 1 1.7 * 10<sup>5</sup>                     1.5 * 10<sup>5</sup>                            1.6 * 10<sup>5</sup>                                   2.6 * 10<sup>5</sup>U266    medium 2 1.2 * 10<sup>5</sup>                     1.2 * 10<sup>5</sup>                            1.9 * 10<sup>5</sup>                                   2.0 * 10<sup>5</sup>U266    medium 3 1.1 * 10<sup>5</sup>                     1.3 * 10<sup>5</sup>                            1.4 * 10<sup>5</sup>                                   3.1 * 10<sup>5</sup>SP2/0   medium 1 1.6 * 10<sup>5</sup>                     1.4 * 10<sup>5</sup>                            12.1 * 10<sup>5</sup>                                   16.7 * 10<sup>5</sup>SP2/0   medium 2 0.7 * 10<sup>5</sup>                     1.5 * 10<sup>5</sup>                            12.5 * 10<sup>5</sup>                                   20.0 * 10<sup>5</sup>SP2/0   medium 3 0.8 * 10<sup>5</sup>                     0.9 * 10<sup>5</sup>                            14.5 * 10<sup>5</sup>                                   19.8 * 10<sup>5</sup>Anti CD20   medium 1 0.8 * 10<sup>5</sup>                     1.3 * 10<sup>5</sup>                            12.9 * 10<sup>5</sup>                                   1.5 * 10<sup>9</sup>Anti CD20   medium 2 1.0 * 10<sup>5</sup>                     1.2 * 10<sup>5</sup>                            11.7 * 10<sup>5</sup>                                   16.5 * 10<sup>5</sup>Anti CD20   medium 3 0.9 * 10<sup>5</sup>                     1.7 * 10<sup>5</sup>                            11.7 * 10<sup>5</sup>                                   13.5 * 10<sup>5</sup>______________________________________</pre>
    
    <heading>EXAMPLE 2</heading> <p>Production of a protein hydrolysate using vital gluten</p>
    <p>A 8% dispersion of vital gluten is hydrolysed with 0.1% (E/S) of the commercially available enzyme preparation pepsin orthana 1:10,000 NF (P.C.A. Diagnostica, Haarlem, The Netherlands) at 50Â° C. for 16 hours. The pH is initially set at pH 1.5 with hydrochloric acid and not controlled during further hydrolysis. After hydrolysis the enzyme is inactivated via a heat treatment of 95Â° C. for 1 minute. Residual intact protein and insoluble components are removed via centrifugation for 5 minutes at 2500 g and the obtained effluent is subsequently ultrafiltered. Preferably membranes with a molecular weight cutoff of 10,000 Dalton are used. The obtained ultrafiltration permeate is concentrated via evaporation and is then spray dried.</p>
    <p>The obtained final product is characterized using the above described methods. The results are summarized in Table 4.</p>
    <p>
      </p> <pre xml:space="preserve" listing-type="tabular">              TABLE 4______________________________________  % AN   0.90  % TN   12.30  % FAA  0.70  PCL    11.9  &gt;10 kD 1.1  5-10 kD         1.0  1-5 kD 7.4  &lt;1 kD  90.5______________________________________         Total Amino                   Free Amino Acids         Acids - mg/g                   mg/gAlanine       25.4      0.7Arginine      24.8      0.0Asparagine +  33.9      0.8Aspartic acidCysteine      4.4       2.1Glutamine +   162.9     0.0Glutamine acidGlycine       21.3      0.1Histidine     13.5      0.0Isoleucine    25.6      0.0Leucine       60.8      0.5Lysine        15.2      0.1Methionine    13.3      0.1Phenylalanine 32.7      0.7Proline       55.0      1.1Serine        39.2      0.2Threonine     23.0      0.1Tyrosine      24.3      0.4Valine        28.6      0.1______________________________________</pre>
    
    <p>Evaluation of the hydrolysate in cell tissue cultures</p>
    <p>Two media were composed on basis of the well known RPMI-1640 medium. This medium was prepared from the RPMI-1640 select Amine kit from Gibco BRL, Life Technologies Inc., Cat No. 17402-017. The medium was divided in two equal portions which were used as basis for medium 1 and 4.</p>
    <p>Medium 1.</p>
    <p>To the basic RPMI-1640 medium obtained from the Gibco's select Amine kit the supplement was added as in Example 1.</p>
    <p>Medium 4</p>
    <p>To the basic RPMI-1640 medium obtained from the Gibco's select Amine kit the supplement without the L-glutamine was added. Instead of L-glutamine as present in the supplement 3.1 g/l of the obtained gluten hydrolysate was added. Additionally the free amino acids cysteine, arginine and hydroxyproline are supplemented to compensate for the low levels of these amino acids in the obtained gluten hydrolysate. The results are summarized in Table 5.</p>
    <p>
      </p> <pre xml:space="preserve" listing-type="tabular">              TABLE 5______________________________________Cell CountsCounts are given in cell per ml.                     after 1                            after 5                                   after 7Cell line   Medium   day 0    day    days   days______________________________________U266    medium 1 1.7 * 10<sup>5</sup>                     1.5 * 10<sup>5</sup>                            1.6 * 10<sup>5</sup>                                   2.6 * 10<sup>5</sup>U266    medium 4 1.4 * 10<sup>5</sup>                     1.1 * 10<sup>5</sup>                            1.3 * 10<sup>5</sup>                                   1.3 * 10<sup>5</sup>SP2/0   medium 1 1.6 * 10<sup>5</sup>                     1.4 * 10<sup>5</sup>                            12.1 * 10<sup>5</sup>                                   16.7 * 10<sup>5</sup>SP2/0   medium 4 1.6 * 10<sup>5</sup>                     1.5 * 10<sup>5</sup>                            13.6 * 10<sup>5</sup>                                   14.9 * 10<sup>5</sup>Anti CD20   medium 1 0.8 * 10<sup>5</sup>                     1.3 * 10<sup>5</sup>                            12.9 * 10<sup>5</sup>                                   1.5 * 10<sup>5</sup>Anti CD20   medium 4 1.1 * 10<sup>5</sup>                     1.2 * 10<sup>5</sup>                            14.0 * 10<sup>5</sup>                                   11.4 * 10<sup>5</sup>______________________________________</pre>
    
    <p>From the results it can be seen that the gluten hydrolysate from this invention does not given an acute cytotoxicity and that the cells can be cultured using the gluten hydrolysate from this invention.</p>
    <p>It is intended that the foregoing description be only illustrative of the present invention and that the present invention be limited only by the hereinafter appended claims.</p>
    </div></div></div><div class="patent-section patent-tabular-section"><a id="backward-citations"></a><div class="patent-section-header"><span class="patent-section-title">Patent Citations</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Cited Patent</th><th class="patent-data-table-th">Filing date</th><th class="patent-data-table-th">Publication date</th><th class="patent-data-table-th">Applicant</th><th class="patent-data-table-th">Title</th></tr></thead><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US3579423">US3579423</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Dec 13, 1968</td><td class="patent-data-table-td patent-date-value">May 18, 1971</td><td class="patent-data-table-td ">Flow Lab</td><td class="patent-data-table-td ">Preparation of tissue culture media</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US3852479">US3852479</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Mar 27, 1973</td><td class="patent-data-table-td patent-date-value">Dec 3, 1974</td><td class="patent-data-table-td ">Kikkoman Shoyu Co Ltd</td><td class="patent-data-table-td ">Process for producing a protein hydrolysate</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US3932671">US3932671</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Mar 20, 1973</td><td class="patent-data-table-td patent-date-value">Jan 13, 1976</td><td class="patent-data-table-td ">Kikkoman Shoyu Co., Ltd.</td><td class="patent-data-table-td ">Process for producing protein hydrolyzate</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4058512">US4058512</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Apr 28, 1975</td><td class="patent-data-table-td patent-date-value">Nov 15, 1977</td><td class="patent-data-table-td ">Ab Kabi</td><td class="patent-data-table-td ">Synthetic peptides having growth promoting activity</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4100151">US4100151</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jan 6, 1977</td><td class="patent-data-table-td patent-date-value">Jul 11, 1978</td><td class="patent-data-table-td ">Novo Industri A/S</td><td class="patent-data-table-td ">Enzymatic modification of corn gluten</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4235772">US4235772</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jun 20, 1979</td><td class="patent-data-table-td patent-date-value">Nov 25, 1980</td><td class="patent-data-table-td ">Ab Kabi</td><td class="patent-data-table-td ">Novel peptides having growth promoting activity</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP0220379A1?cl=en">EP0220379A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Jul 3, 1986</td><td class="patent-data-table-td patent-date-value">May 6, 1987</td><td class="patent-data-table-td ">Pharmacia GmbH</td><td class="patent-data-table-td ">Use of glutamine in the form of its di- and tripeptide in a nutrient medium for cell culture</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="http://www.google.com/url?id=rsNFBAABERAJ&amp;q=http://worldwide.espacenet.com/publicationDetails/biblio%3FCC%3DJP%26NR%3DH0249579A%26KC%3DA%26FT%3DD&amp;usg=AFQjCNHD5Ow_nZwHxFRRsO8iUBEe2_x8gA">JPH0249579A</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td "> </td><td class="patent-data-table-td citation-no-title">Title not available</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="http://www.google.com/url?id=rsNFBAABERAJ&amp;q=http://worldwide.espacenet.com/publicationDetails/biblio%3FCC%3DJP%26NR%3DH0418769A%26KC%3DA%26FT%3DD&amp;usg=AFQjCNGB8NcjH-g_l_-5qCMXmaK2u_hEIQ">JPH0418769A</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td "> </td><td class="patent-data-table-td citation-no-title">Title not available</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="http://www.google.com/url?id=rsNFBAABERAJ&amp;q=http://worldwide.espacenet.com/publicationDetails/biblio%3FCC%3DJP%26NR%3DH05236909A%26KC%3DA%26FT%3DD&amp;usg=AFQjCNGUWooQLpOevLUbFi3A-kl-mY8_OA">JPH05236909A</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td patent-date-value"></td><td class="patent-data-table-td "> </td><td class="patent-data-table-td citation-no-title">Title not available</td></tr></table><div class="patent-section-footer">* Cited by examiner</div></div><div class="patent-section patent-tabular-section"><a id="npl-citations"></a><div class="patent-section-header"><span class="patent-section-title">Non-Patent Citations</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th colspan="3"class="patent-data-table-th">Reference</th></tr></thead><tr><td class="patent-data-table-td ">1</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Animal Cell Culture, A Practical Approach, Second Edition, ISBN 0 19 963213 8.</td></tr><tr><td class="patent-data-table-td ">2</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Animal Cell Culture, A Practical Approach, Second Edition, ISBN 0-19-963213-8.</td></tr><tr><td class="patent-data-table-td ">3</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Babcock et al. "<a href='http://scholar.google.com/scholar?q="J.+of+Nutrition"'>J. of Nutrition</a>", v. 93, #3, Nov. 1967 pp. 368-376.</td></tr><tr><td class="patent-data-table-td ">4</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Babcock et al. J. of Nutrition , v. 93, 3, Nov. 1967 pp. 368 376.</td></tr><tr><td class="patent-data-table-td ">5</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Belitz, H.P. et al, p. 285 297, plus eng. transl., source unknown, 1982.</td></tr><tr><td class="patent-data-table-td ">6</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Belitz, H.P. et al, p. 285-297, plus eng. transl., source unknown, 1982.</td></tr><tr><td class="patent-data-table-td ">7</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Brand, K., et al., Metabolism 38:29 33 (1989).</td></tr><tr><td class="patent-data-table-td ">8</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Brand, K., et al., Metabolism 38:29-33 (1989).</td></tr><tr><td class="patent-data-table-td ">9</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Heeneman et al, J. Immunological Methods, 116, 85 91 (1991).</td></tr><tr><td class="patent-data-table-td ">10</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Heeneman et al, J. Immunological Methods, 116, 85-91 (1991).</td></tr><tr><td class="patent-data-table-td ">11</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Ishii, K. et al., J. of Household Soc. of Japan, v. 45(9), pp. 791 796, plus eng. tranl., 1994.</td></tr><tr><td class="patent-data-table-td ">12</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Ishii, K. et al., J. of Household Soc. of Japan, v. 45(9), pp. 791-796, plus eng. tranl., 1994.</td></tr><tr><td class="patent-data-table-td ">13</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">MacRitchie, J. Food Technol. 14, 595, 601 (1979).</td></tr><tr><td class="patent-data-table-td ">14</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Nedelkovits, J. et al., Food Investigation Gazette, v. 16(4 5) pp. 211 216, plus eng. transl. 1970.</td></tr><tr><td class="patent-data-table-td ">15</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Nedelkovits, J. et al., Food Investigation Gazette, v. 16(4-5) pp. 211-216, plus eng. transl. 1970.</td></tr><tr><td class="patent-data-table-td ">16</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Tenabe et al., Journal of Food Biochemistry, 16:235 248 (1993).</td></tr><tr><td class="patent-data-table-td ">17</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Tenabe et al., Journal of Food Biochemistry, 16:235-248 (1993).</td></tr><tr><td class="patent-data-table-td ">18</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Yoong et al "<a href='http://scholar.google.com/scholar?q="Food+Chem."'>Food Chem.</a>" v. 51 #2, 1994, pp. 271-274.</td></tr><tr><td class="patent-data-table-td ">19</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Yoong et al Food Chem. v. 51 2, 1994, pp. 271 274.</td></tr></table><div class="patent-section-footer">* Cited by examiner</div></div><div class="patent-section patent-tabular-section"><a id="forward-citations"></a><div class="patent-section-header"><span class="patent-section-title">Referenced by</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Citing Patent</th><th class="patent-data-table-th">Filing date</th><th class="patent-data-table-th">Publication date</th><th class="patent-data-table-th">Applicant</th><th class="patent-data-table-th">Title</th></tr></thead><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6103529">US6103529</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Oct 10, 1997</td><td class="patent-data-table-td patent-date-value">Aug 15, 2000</td><td class="patent-data-table-td ">Life Technologies, Inc.</td><td class="patent-data-table-td ">Animal cell culture media comprising peptides derived from rice</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6716452">US6716452</a></td><td class="patent-data-table-td patent-date-value">Aug 22, 2000</td><td class="patent-data-table-td patent-date-value">Apr 6, 2004</td><td class="patent-data-table-td ">New River Pharmaceuticals Inc.</td><td class="patent-data-table-td ">Composition comprising polypeptide which is heteropolymer of two or more synthetic amino acids and active agent covalently attached to side chain, in form suitable for oral administration and release of active agent into bloodstream</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7018654">US7018654</a></td><td class="patent-data-table-td patent-date-value">Nov 8, 2001</td><td class="patent-data-table-td patent-date-value">Mar 28, 2006</td><td class="patent-data-table-td ">New River Pharmaceuticals Inc.</td><td class="patent-data-table-td ">Pharmaceutical composition containing an active agent in an amino acid copolymer structure</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7214401">US7214401</a></td><td class="patent-data-table-td patent-date-value">Dec 4, 2002</td><td class="patent-data-table-td patent-date-value">May 8, 2007</td><td class="patent-data-table-td ">Quest International B.V.</td><td class="patent-data-table-td ">Method of manufacturing an aerated carbohydrate containing food product</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7955833">US7955833</a></td><td class="patent-data-table-td patent-date-value">Jul 8, 2003</td><td class="patent-data-table-td patent-date-value">Jun 7, 2011</td><td class="patent-data-table-td ">Baxter International Inc.</td><td class="patent-data-table-td ">Derived from soy hydrolysate and yeast hydrolysate; useful for cultivating cells, such as recombinant cells or cells infected with a virus, and for production biological products by cell culture processes under conditions devoid of animal proteins</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8021881">US8021881</a></td><td class="patent-data-table-td patent-date-value">Aug 20, 2007</td><td class="patent-data-table-td patent-date-value">Sep 20, 2011</td><td class="patent-data-table-td ">Baxter Innovations Gmbh</td><td class="patent-data-table-td ">Medium for the protein-free and serum-free cultivation of cells</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8080414">US8080414</a></td><td class="patent-data-table-td patent-date-value">Jun 19, 2009</td><td class="patent-data-table-td patent-date-value">Dec 20, 2011</td><td class="patent-data-table-td ">Baxter Innovations Gmbh</td><td class="patent-data-table-td ">Recombinant cell clones having increased stability and methods of making and using the same</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8084251">US8084251</a></td><td class="patent-data-table-td patent-date-value">May 12, 2010</td><td class="patent-data-table-td patent-date-value">Dec 27, 2011</td><td class="patent-data-table-td ">Baxter Innovations Gmbh</td><td class="patent-data-table-td ">Recombinant cell clones having increased stability and methods of making and using the same</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8084252">US8084252</a></td><td class="patent-data-table-td patent-date-value">Aug 2, 2010</td><td class="patent-data-table-td patent-date-value">Dec 27, 2011</td><td class="patent-data-table-td ">Baxter Innovations Gmbh</td><td class="patent-data-table-td ">Recombinant cell clones having increased stability and methods of making and using the same</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8106016">US8106016</a></td><td class="patent-data-table-td patent-date-value">Dec 8, 2006</td><td class="patent-data-table-td patent-date-value">Jan 31, 2012</td><td class="patent-data-table-td ">Shire Llc</td><td class="patent-data-table-td ">Compounds and compositions for prevention of overdose of oxycodone</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8329465">US8329465</a></td><td class="patent-data-table-td patent-date-value">Jan 6, 2011</td><td class="patent-data-table-td patent-date-value">Dec 11, 2012</td><td class="patent-data-table-td ">Baxter Innovations Gmbh</td><td class="patent-data-table-td ">Recombinant cell clones having increased stability and methods of making and using the same</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8343927">US8343927</a></td><td class="patent-data-table-td patent-date-value">Sep 13, 2010</td><td class="patent-data-table-td patent-date-value">Jan 1, 2013</td><td class="patent-data-table-td ">Shire Llc</td><td class="patent-data-table-td ">Pharmaceutical compositions for prevention of overdose or abuse</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8394813">US8394813</a></td><td class="patent-data-table-td patent-date-value">Jul 8, 2008</td><td class="patent-data-table-td patent-date-value">Mar 12, 2013</td><td class="patent-data-table-td ">Shire Llc</td><td class="patent-data-table-td ">Active agent delivery systems and methods for protecting and administering active agents</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8440408">US8440408</a></td><td class="patent-data-table-td patent-date-value">Dec 10, 2010</td><td class="patent-data-table-td patent-date-value">May 14, 2013</td><td class="patent-data-table-td ">Baxter International Inc.</td><td class="patent-data-table-td ">Animal protein-free media for cultivation of cells</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8524497">US8524497</a></td><td class="patent-data-table-td patent-date-value">May 6, 2011</td><td class="patent-data-table-td patent-date-value">Sep 3, 2013</td><td class="patent-data-table-td ">Baxter International Inc.</td><td class="patent-data-table-td ">Animal protein free media for cultivation of cells</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8722406">US8722406</a></td><td class="patent-data-table-td patent-date-value">Aug 4, 2011</td><td class="patent-data-table-td patent-date-value">May 13, 2014</td><td class="patent-data-table-td ">Baxter Innovations Gmbh</td><td class="patent-data-table-td ">Medium for the protein-free and serum-free cultivation of cells</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US8748156">US8748156</a></td><td class="patent-data-table-td patent-date-value">Apr 16, 2013</td><td class="patent-data-table-td patent-date-value">Jun 10, 2014</td><td class="patent-data-table-td ">Baxter International Inc.</td><td class="patent-data-table-td ">Animal protein-free media for cultivation of cells</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP1327390A1?cl=en">EP1327390A1</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Dec 4, 2001</td><td class="patent-data-table-td patent-date-value">Jul 16, 2003</td><td class="patent-data-table-td ">Quest International B.V.</td><td class="patent-data-table-td ">Method of manufacturing an aerated carbohydrate containing food product</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2213724A1?cl=en">EP2213724A1</a></td><td class="patent-data-table-td patent-date-value">Oct 12, 2005</td><td class="patent-data-table-td patent-date-value">Aug 4, 2010</td><td class="patent-data-table-td ">Baxter International Inc.</td><td class="patent-data-table-td ">Animal protein-free media for cultivation of cells</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2213725A1?cl=en">EP2213725A1</a></td><td class="patent-data-table-td patent-date-value">Oct 12, 2005</td><td class="patent-data-table-td patent-date-value">Aug 4, 2010</td><td class="patent-data-table-td ">Baxter International Inc.</td><td class="patent-data-table-td ">Animal protein-free media for cultivation of cells</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2213726A1?cl=en">EP2213726A1</a></td><td class="patent-data-table-td patent-date-value">Oct 12, 2005</td><td class="patent-data-table-td patent-date-value">Aug 4, 2010</td><td class="patent-data-table-td ">Baxter International Inc.</td><td class="patent-data-table-td ">Animal protein-free media for cultivation of cells</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2218776A1?cl=en">EP2218776A1</a></td><td class="patent-data-table-td patent-date-value">Oct 12, 2005</td><td class="patent-data-table-td patent-date-value">Aug 18, 2010</td><td class="patent-data-table-td ">Baxter International Inc.</td><td class="patent-data-table-td ">Animal protein-free media for cultivation of cells</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2500413A1?cl=en">EP2500413A1</a></td><td class="patent-data-table-td patent-date-value">Sep 13, 2007</td><td class="patent-data-table-td patent-date-value">Sep 19, 2012</td><td class="patent-data-table-td ">Abbott Laboratories</td><td class="patent-data-table-td ">Cell culture improvements</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2500414A1?cl=en">EP2500414A1</a></td><td class="patent-data-table-td patent-date-value">Sep 13, 2007</td><td class="patent-data-table-td patent-date-value">Sep 19, 2012</td><td class="patent-data-table-td ">Abbott Laboratories</td><td class="patent-data-table-td ">Cell culture improvements</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2500415A1?cl=en">EP2500415A1</a></td><td class="patent-data-table-td patent-date-value">Sep 13, 2007</td><td class="patent-data-table-td patent-date-value">Sep 19, 2012</td><td class="patent-data-table-td ">Abbott Laboratories</td><td class="patent-data-table-td ">Cell culture improvements</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2500416A1?cl=en">EP2500416A1</a></td><td class="patent-data-table-td patent-date-value">Sep 13, 2007</td><td class="patent-data-table-td patent-date-value">Sep 19, 2012</td><td class="patent-data-table-td ">Abbott Laboratories</td><td class="patent-data-table-td ">Cell culture improvements</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2527425A1?cl=en">EP2527425A1</a></td><td class="patent-data-table-td patent-date-value">Sep 13, 2007</td><td class="patent-data-table-td patent-date-value">Nov 28, 2012</td><td class="patent-data-table-td ">Abbott Laboratories</td><td class="patent-data-table-td ">Cell culture improvements</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/EP2532737A2?cl=en">EP2532737A2</a></td><td class="patent-data-table-td patent-date-value">Sep 13, 2007</td><td class="patent-data-table-td patent-date-value">Dec 12, 2012</td><td class="patent-data-table-td ">Abbott Laboratories</td><td class="patent-data-table-td ">Cell culture improvements</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/WO2010078450A1?cl=en">WO2010078450A1</a></td><td class="patent-data-table-td patent-date-value">Dec 30, 2009</td><td class="patent-data-table-td patent-date-value">Jul 8, 2010</td><td class="patent-data-table-td ">Baxter International Inc.</td><td class="patent-data-table-td ">Method of enhancing cell growth using alkyl-amine-n-oxide (aanox)</td></tr></table><div class="patent-section-footer">* Cited by examiner</div></div><div class="patent-section patent-tabular-section"><a id="classifications"></a><div class="patent-section-header"><span class="patent-section-title">Classifications</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th"> </th><th class="patent-data-table-th"> </th></tr></thead><tr><td class="patent-data-table-td ">U.S. Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=rsNFBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc435/defs435.htm&usg=AFQjCNFivWgFr8pvtdk7qYLW9R7yxFP7Dg#C435S348000">435/348</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=rsNFBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc435/defs435.htm&usg=AFQjCNFivWgFr8pvtdk7qYLW9R7yxFP7Dg#C435S366000">435/366</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=rsNFBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc435/defs435.htm&usg=AFQjCNFivWgFr8pvtdk7qYLW9R7yxFP7Dg#C435S404000">435/404</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=rsNFBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc435/defs435.htm&usg=AFQjCNFivWgFr8pvtdk7qYLW9R7yxFP7Dg#C435S325000">435/325</a></span></td></tr><tr><td class="patent-data-table-td ">International Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=rsNFBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=C12N0005000000">C12N5/00</a></span></td></tr><tr><td class="patent-data-table-td ">Cooperative Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=rsNFBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=C12N5/0018">C12N5/0018</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=rsNFBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=C12N2500/76">C12N2500/76</a></span></td></tr><tr><td class="patent-data-table-td ">European Classification</td><td class="patent-data-table-td "><span class="nested-value">C12N5/00M</span></td></tr></table><div class="patent-section-footer"></div></div><div class="patent-section patent-tabular-section"><a id="legal-events"></a><div class="patent-section-header"><span class="patent-section-title">Legal Events</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Date</th><th class="patent-data-table-th">Code</th><th class="patent-data-table-th">Event</th><th class="patent-data-table-th">Description</th></tr></thead><tr><td class="patent-data-table-td patent-date-value">Dec 20, 2011</td><td class="patent-data-table-td ">B1</td><td class="patent-data-table-td ">Reexamination certificate first reexamination</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">CLAIMS 1-19 ARE CANCELLED. NEW CLAIMS 20-25 ARE ADDED AND DETERMINED TO BE PATENTABLE.</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Sep 28, 2009</td><td class="patent-data-table-td ">FPAY</td><td class="patent-data-table-td ">Fee payment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Year of fee payment: </span><span class="nested-value">12</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Jul 28, 2009</td><td class="patent-data-table-td ">RR</td><td class="patent-data-table-td ">Request for reexamination filed</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20090610</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Oct 14, 2005</td><td class="patent-data-table-td ">FPAY</td><td class="patent-data-table-td ">Fee payment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Year of fee payment: </span><span class="nested-value">8</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Nov 19, 2001</td><td class="patent-data-table-td ">FPAY</td><td class="patent-data-table-td ">Fee payment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Year of fee payment: </span><span class="nested-value">4</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Nov 19, 2001</td><td class="patent-data-table-td ">SULP</td><td class="patent-data-table-td ">Surcharge for late payment</td><td class="patent-data-table-td "></td></tr><tr><td class="patent-data-table-td patent-date-value">Apr 19, 1995</td><td class="patent-data-table-td ">AS</td><td class="patent-data-table-td ">Assignment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">QUEST INTERNATIONAL FLAVORS &amp; FOOD INGREDIENTS COM</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:BLOM, WIM R.;KUNST, ANTHONIE;VAN SCHIE, BART J.;AND OTHERS;REEL/FRAME:007444/0255;SIGNING DATES FROM 19950227 TO 19950301</span></div></td></tr></table><div class="patent-section-footer"></div></div><div class="modal-dialog" id="patent-images-lightbox"><div class="patent-lightbox-controls"><div class="patent-lightbox-rotate-controls"><div class="patent-lightbox-rotation-text">Rotate</div><div class="rotate-icon rotate-ccw-icon"></div><div class="rotate-icon rotate-cw-icon"></div></div><div class="patent-lightbox-index-counter"></div><a class="patent-lightbox-fullsize-link" target="_blank">Original Image</a><div class="patent-drawings-control patent-drawings-next"><img class="patent-drawings-button-img"src="/googlebooks/images/kennedy/page_right.png" alt="Next page"width="21" height="21" /></div><div class="patent-drawings-control patent-drawings-prev"><img class="patent-drawings-button-img"src="/googlebooks/images/kennedy/page_left.png" alt="Previous page"width="21" height="21" /></div></div><div class="modal-dialog-content"><div class="patent-lightbox-image-holder"><div class="patent-lightbox-placeholder"></div></div></div></div><script>_OC_initPatentsAtb({image_not_available_html: " Image not available"});</script></div></div></div></td></tr></table><script>(function() {var href = window.location.href;if (href.indexOf('?') !== -1) {var parameters = href.split('?')[1].split('&');for (var i = 0; i < parameters.length; i++) {var param = parameters[i].split('=');if (param[0] == 'focus') {var elem = document.getElementById(param[1]);if (elem) {elem.focus();}}}}})();</script><script>_OC_addFlags({LockSrc:"/books/javascript/lock_8a2b04e7bf975d5171d8e4c0b6365c7a.js", Host:"http://www.google.com/", IsBooksRentalEnabled:1, IsWebstoreDisplayCaseEnabled:1, IsObfuscationEnabled:1, IsBrowsingHistoryEnabled:1, IsWebReaderSvgEnabled:0, IsGeoLayerEnabled:1, IsImageModeNotesEnabled:1, IsCopyMenuItemEnabled:1, IsGiftingEnabled:0, IsWebReaderUniversalPaginatorEnabled:0, IsOfflineBubbleEnabled:1, IsReaderEnabledForPlayRequests:1, IsFutureOnSaleVolumesEnabled:1, IsOfflineRestrictedCopyEnabled:1, IsBooksUnifiedLeftNavEnabled:1, IsRestrictedCopyEnabled:1, IsZipitFolderCollectionEnabled:1, IsEndOfSampleRecommendationsEnabled:1, IsRatingsOnBookcardsEnabled:1, IsAdsDisabled:0, IsIframePageDisplayEnabled:0, IsEmbeddedMediaEnabled:1, IsImageModeAnnotationsEnabled:1, IsMyLibraryGooglePlusEnabled:1, IsImagePageProviderEnabled:0, IsBookcardListPriceSmall:0, IsInternalUser:0, IsBooksShareButtonEnabled:0, IsPreOrdersEnabled:0, IsDisabledRandomBookshelves:0, WebstoreDisplayCasePosition:3});_OC_Run({"enable_p13n":false,"add_vol_to_collection_base_url":"http://www.google.com/patents?op=add\u0026sig=ACfU3U38Btfa4esmjnutOYSdcpuPm3GpXQ\u0026id=rsNFBAABERAJ","remove_vol_from_collection_base_url":"http://www.google.com/patents?op=remove\u0026sig=ACfU3U3B7QiY8Qh7OJM62OylhBejABHE_Q\u0026id=rsNFBAABERAJ","logged_in":false,"p13n_save_user_settings_url":"http://www.google.com/patents?op=edit_user_settings\u0026sig=ACfU3U22t6DFC0tz9I0KbNd6QuX-5f-0LA","is_cobrand":false,"sign_in_url":"https://www.google.com/accounts/Login?service=\u0026continue=http://www.google.com/patents%3Fhl%3Den\u0026hl=en","is_play_enabled":true}, {"volume_id":"","is_ebook":true,"volumeresult":{"has_flowing_text":false,"has_scanned_text":true,"can_download_pdf":false,"can_download_epub":false,"is_pdf_drm_enabled":false,"is_epub_drm_enabled":false,"download_pdf_url":"http://www.google.com/patents/download/Method_for_in_vitro_cell_growth_of_eucar.pdf?id=rsNFBAABERAJ\u0026output=pdf\u0026sig=ACfU3U3yeXYX74MqgOwMoSyz_fhLRmHwBQ"},"sample_url":"http://www.google.com/patents/reader?id=rsNFBAABERAJ\u0026printsec=frontcover\u0026output=reader\u0026source=gbs_atb_hover","is_browsable":true,"is_public_domain":true}, {});</script><div id="footer_table" style="font-size:83%;text-align:center;position:relative;top:20px;height:4.5em;margin-top:2em"><div style="margin-bottom:8px"><a href=http://www.google.com/><nobr>Google&nbsp;Home</nobr></a> - <a href=//www.google.com/patents/sitemap/><nobr>Sitemap</nobr></a> - <a href=http://www.google.com/googlebooks/uspto.html><nobr>USPTO Bulk Downloads</nobr></a> - <a href=/intl/en/privacy/><nobr>Privacy Policy</nobr></a> - <a href=/intl/en/policies/terms/><nobr>Terms of Service</nobr></a> - <a href=https://support.google.com/faqs/answer/2539193?hl=en><nobr>About Google Patents</nobr></a> - <a href="http://www.google.com/tools/feedback/intl/en/error.html" onclick="try{_OC_startFeedback({productId: '72792',locale: 'en'});return false;}catch(e){}"><nobr>Send Feedback</nobr></a></div><span>Data provided by IFI CLAIMS Patent Services</span><br><span >&copy;2012 Google</span></div> <script type="text/javascript">var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));</script><script type="text/javascript">var pageTracker = _gat._getTracker("UA-27188110-1");pageTracker._setCookiePath("/patents/");pageTracker._trackPageview();</script> </body></html>